Hereditary angioedema--therapies old and new.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed.

1. Global research trends in hereditary angioedema, 1972-2023: Bibliometric analysis of productivity, collaboration, and thematic evolution.The World Allergy Organization journal · 2026
   Article
2. Presentation of an extraordinary colic: abdominal pain as the first and only utterance of an acquired C1-inhibitor deficiency.BMJ case reports · 2022
   Article
3. Immunological Basis of the Endometriosis: The Complement System as a Potential Therapeutic Target.Frontiers in immunology · 2020
   Review
4. Lethal manifestations of angioedema.Forensic science, medicine, and pathology · 2019
   Article
5. Evaluation and Management of Angioedema in the Emergency Department.The western journal of emergency medicine · 2019
   Review
6. Impaired Endothelial Function in Hereditary Angioedema During the Symptom-Free Period.Frontiers in physiology · 2018
   Article
7. Expanding horizons in complement drug discovery: challenges and emerging strategies.Seminars in immunopathology · 2018
   Review
8. Hereditary Angioedema as a Metabolic Liver Disorder: Novel Therapeutic Options and Prospects for Cure.Frontiers in immunology · 2016
   Article
9. Hereditary angioedema: what the gastroenterologist needs to know.Clinical and experimental gastroenterology · 2014
   Review
10. The prophylactic use of C1 inhibitor in hereditary angioedema patients undergoing invasive surgical procedures: a retrospective study.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2014
    Article
11. "Surgical" abdomen in a patient with chronic lymphocytic leukemia: a case of acquired angioedema.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2011
    Article

Corrections and comments

• Commented on by
  Therapeutic agents for hereditary angioedema.2011
• Comment on
  Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema.2010
• Comment on
  Ecallantide for the treatment of acute attacks in hereditary angioedema.2010
• Comment on
  Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema.2010
• Erratum issued

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as